TFRC and cancer: Cancer cells with mutant RAS (including KRAS), such as HNSCC cells, are sensitive to the induction of ferroptosis, which may be due to the mutated expression of iron metabolism genes mediated by RAS, such as transferrin receptor TFRC, FTH1 and FTL.